These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 32993146)

  • 1. Chemically Diverse and Biologically Active Secondary Metabolites from Marine
    Shah SAA; Hassan SSU; Bungau S; Si Y; Xu H; Rahman MH; Behl T; Gitea D; Pavel FM; Corb Aron RA; Pasca B; Nemeth S
    Mar Drugs; 2020 Sep; 18(10):. PubMed ID: 32993146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repurposing drugs against the main protease of SARS-CoV-2: mechanism-based insights supported by available laboratory and clinical data.
    Chakraborti S; Bheemireddy S; Srinivasan N
    Mol Omics; 2020 Oct; 16(5):474-491. PubMed ID: 32696772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19: therapeutic approaches description and discussion.
    Trindade GG; Caxito SMC; Xavier AREO; Xavier MAS; BrandÃo F
    An Acad Bras Cienc; 2020; 92(2):e20200466. PubMed ID: 32556054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization Rules for SARS-CoV-2 M
    Stoddard SV; Stoddard SD; Oelkers BK; Fitts K; Whalum K; Whalum K; Hemphill AD; Manikonda J; Martinez LM; Riley EG; Roof CM; Sarwar N; Thomas DM; Ulmer E; Wallace FE; Pandey P; Roy S
    Viruses; 2020 Aug; 12(9):. PubMed ID: 32859008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repurposing old drugs as antiviral agents for coronaviruses.
    Yang CW; Peng TT; Hsu HY; Lee YZ; Wu SH; Lin WH; Ke YY; Hsu TA; Yeh TK; Huang WZ; Lin JH; Sytwu HK; Chen CT; Lee SJ
    Biomed J; 2020 Aug; 43(4):368-374. PubMed ID: 32563698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural Biology Aids the Research of New Anti-COVID-19 Drugs.
    Lu J; Liu X
    Curr Org Synth; 2020; 17(3):162-163. PubMed ID: 32538717
    [No Abstract]   [Full Text] [Related]  

  • 7. HIV and SARS-CoV-2: points to consider to face this new pandemic.
    Prieto Pozo AA; Salvador Sagüez FLD
    Medwave; 2020 Oct; 20(9):e8049. PubMed ID: 33141814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Importance of Environmental Factors on Production of Computationally- Defined Natural Molecules against COVID-19 Pandemic.
    Abouleish M; El-Keblawy A; Mosa KA; Soliman SSM
    Curr Top Med Chem; 2020; 20(22):1958-1961. PubMed ID: 33040729
    [No Abstract]   [Full Text] [Related]  

  • 9. Shedding Light on the Effect of Natural Anti-Herpesvirus Alkaloids on SARS-CoV-2: A Treatment Option for COVID-19.
    Hassan STS
    Viruses; 2020 Apr; 12(4):. PubMed ID: 32340120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can Bioactive Lipids Inactivate Coronavirus (COVID-19)?
    Das UN
    Arch Med Res; 2020 Apr; 51(3):282-286. PubMed ID: 32229155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Not Available].
    Nau JY
    Rev Med Suisse; 2020 Mar; 16(685):510-511. PubMed ID: 32167254
    [No Abstract]   [Full Text] [Related]  

  • 12. In Silico Evaluation of the Effectivity of Approved Protease Inhibitors against the Main Protease of the Novel SARS-CoV-2 Virus.
    Eleftheriou P; Amanatidou D; Petrou A; Geronikaki A
    Molecules; 2020 May; 25(11):. PubMed ID: 32485894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 RNA polymerase as target for antiviral therapy.
    Buonaguro L; Tagliamonte M; Tornesello ML; Buonaguro FM
    J Transl Med; 2020 May; 18(1):185. PubMed ID: 32370758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. News Feature: To counter the pandemic, clinicians bank on repurposed drugs.
    Madhusoodanan J
    Proc Natl Acad Sci U S A; 2020 May; 117(20):10616-10620. PubMed ID: 32350142
    [No Abstract]   [Full Text] [Related]  

  • 15. Design of Potent Membrane Fusion Inhibitors against SARS-CoV-2, an Emerging Coronavirus with High Fusogenic Activity.
    Zhu Y; Yu D; Yan H; Chong H; He Y
    J Virol; 2020 Jul; 94(14):. PubMed ID: 32376627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a repurposed drug as an inhibitor of Spike protein of human coronavirus SARS-CoV-2 by computational methods.
    Unni S; Aouti S; Thiyagarajan S; Padmanabhan B
    J Biosci; 2020; 45(1):. PubMed ID: 33184246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Not Available].
    Nau JY
    Rev Med Suisse; 2020 Jun; 16(697):1218-1219. PubMed ID: 32520464
    [No Abstract]   [Full Text] [Related]  

  • 18. Medicinal Purposes: Bioactive Metabolites from Marine-derived Organisms.
    Li T; Ding T; Li J
    Mini Rev Med Chem; 2019; 19(2):138-164. PubMed ID: 28969543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Investigation of SARS-CoV-2 Proteins and Their Interactions with Antiviral Drugs.
    Calligari P; Bobone S; Ricci G; Bocedi A
    Viruses; 2020 Apr; 12(4):. PubMed ID: 32295237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secondary Metabolites from Marine Micromonospora: Chemistry and Bioactivities.
    Qi S; Gui M; Li H; Yu C; Li H; Zeng Z; Sun P
    Chem Biodivers; 2020 Apr; 17(4):e2000024. PubMed ID: 32100940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.